Expression of the hMICL in acute myeloid leukemia: a highly reliable disease marker at diagnosis and during follow-up

Hanne Ø Larsen, Anne S Roug, Tom Just, Gordon D Brown, Peter Hokland

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)

Abstract

Stable flow cytometric markers for malignant myeloid cells are highly warranted. Based on data from stem cell research, we hypothesized that the human inhibitory C-type lectin like receptor (hMICL) might represent a novel diagnostic and prognostic vehicle in a standard flow cytometry (FCM) setting.
Original languageEnglish
Pages (from-to)3-8
Number of pages6
JournalCytometry Part B: Clinical Cytometry
Volume82B
Issue number1
Early online date30 Aug 2011
DOIs
Publication statusPublished - Jan 2012

Keywords

  • AML
  • hMICL
  • immunophenotyping
  • LAIP
  • MRD

Fingerprint Dive into the research topics of 'Expression of the hMICL in acute myeloid leukemia: a highly reliable disease marker at diagnosis and during follow-up'. Together they form a unique fingerprint.

Cite this